Studies have shown that the overexpression of YTHDF2 in hepatocellular carcinoma (HCC) can inhibit tumor cell growth, whereas the knockout of the YTHDF2 gene promotes angiogenic sprouting in human umbilical vein endothelial cells (HUVECs). Here, YTHDF2 is linked to neoplasm.